{"article":{"annotation":{"article_id":"ema-prac-october-2026-pharmacovigilance-outcomes","available_at":"2026-10-12T09:41:45.342573Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"360f1a7e38b1ffd63f964c457f1b37aad76751aca0826ffe31110b3e43e9287b","input_sha256":"67fe6f7519bf041750c9f6477bf1f919fdadb2040ea2111e73f5a89945120c52","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october","https://www.ema.europa.eu/no/committees/pharmacovigilance-risk-assessment-committee-prac"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=tr","category":"health","content":{"key_points":[],"paragraphs":["EMA’nın PRAC güvenlik komitesi 28 Eylül–1 Ekim toplantısının ardından ekim istatistiklerini yayımladı. Ajansın aylık özetinde 85 periyodik güvenlilik güncelleme raporu için tekil değerlendirme, merkezi ruhsatlı ilaçlar için 49 risk yönetim planı ve 16 ruhsat sonrası güvenlilik çalışması bulunuyor.","Komite 9 güvenlik sinyali bildirdi: 5’i başlatılmış, 4’ü süren veya sonuçlanan süreçler olarak listelendi. EMA, toplantıda herhangi bir sevk prosedürünün başlatılmadığını ya da sonuçlandırılmadığını belirtti. Bu sayılar bir zarar bulgusunun veya yeni bir kısıtlamanın kanıtı değildir.","Ajans, aylık istatistiklerin taslak gündeme dayandığını söylüyor. Güvenlik sinyali daha fazla inceleme gerektirebilecek olası bir ilaç-olay ilişkisine işaret eder; tek başına nedensellik kanıtı değildir."],"sections":[]},"corrections":[{"at":"2026-10-07T00:56:16+03:00","language":"tr","text":"Bu habere Almanca ve Portekizce çeviriler ile veri ve düzeltme açıklamalarının bu dillerdeki karşılıkları eklendi."},{"at":"2026-10-12T06:19:32+03:00","language":"tr","text":"Veri etiketlerindeki veya açıklamalarındaki çeviri ifadeleri düzeltildi."}],"country":null,"data":{"blocks":[{"description":{"ar":"أعداد التقييمات الشهرية استناداً إلى جدول الأعمال الأولي.","de":"Monatliche Bewertungszahlen auf Grundlage des Entwurfs der Tagesordnung.","en":"Monthly assessment counts based on the draft agenda.","es":"Recuentos mensuales de evaluaciones según el proyecto de orden del día.","fr":"Nombre mensuel d’évaluations selon le projet d’ordre du jour.","pt":"Contagens mensais de avaliações com base na pauta preliminar.","tr":"Taslak gündeme dayalı aylık değerlendirme sayıları."},"id":"verified-indicators","items":[{"basis":"observed","label":{"ar":"إشارات السلامة","de":"Sicherheitssignale","en":"Safety signals","es":"Señales de seguridad","fr":"Signaux de sécurité","pt":"Sinais de segurança","tr":"Güvenlik sinyalleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-safety-signals","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":9},{"basis":"observed","label":{"ar":"التقييمات المنفردة لتقارير PSUR","de":"Einzelbewertungen von PSUR","en":"PSUR single assessments","es":"Evaluaciones únicas de PSUR","fr":"Évaluations uniques de PSUR","pt":"Avaliações individuais de PSUR","tr":"PSUR tekil değerlendirmeleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-psur-single-assessments","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":85},{"basis":"observed","label":{"ar":"خطط إدارة مخاطر الأدوية المرخصة مركزياً","de":"Risikomanagementpläne für zentral zugelassene Arzneimittel","en":"Risk-management plans for centrally authorised medicines","es":"Planes de gestión de riesgos para medicamentos autorizados mediante procedimiento centralizado","fr":"Plans de gestion des risques pour les médicaments autorisés par procédure centralisée","pt":"Planos de gerenciamento de riscos para medicamentos autorizados por procedimento centralizado","tr":"Merkezi ruhsatlı ilaçlar için risk yönetim planları"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-central-risk-plans","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":49},{"basis":"observed","label":{"ar":"دراسات السلامة بعد الترخيص","de":"Sicherheitsstudien nach der Zulassung","en":"Post-authorisation safety studies","es":"Estudios de seguridad posteriores a la autorización","fr":"Études de sécurité post-autorisation","pt":"Estudos de segurança pós-autorização","tr":"Ruhsat sonrası güvenlilik çalışmaları"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-post-authorisation-safety-studies","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":16},{"basis":"observed","label":{"ar":"إجراءات الإحالة التي بدأت أو استمرت أو اختُتمت","de":"Begonnene, laufende oder abgeschlossene Befassungsverfahren","en":"Referrals started, ongoing or concluded","es":"Remisiones iniciadas, en curso o concluidas","fr":"Saisines commencées, en cours ou conclues","pt":"Procedimentos de encaminhamento iniciados, em andamento ou concluídos","tr":"Başlatılan, süren veya sonuçlanan sevk prosedürleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-referral-procedures","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":0}],"methodology":{"ar":"إشارة السلامة ليست دليلاً على السببية؛ وجميع الأعداد مبنية على جدول الأعمال الأولي.","de":"Ein Sicherheitssignal beweist keine Ursache; alle Zahlen beruhen auf dem Entwurf der Tagesordnung.","en":"A safety signal is not proof of causation; all counts are based on the draft agenda.","es":"Una señal de seguridad no prueba causalidad; todos los recuentos se basan en el proyecto del orden del día.","fr":"Un signal de sécurité ne prouve pas la causalité ; tous les chiffres reposent sur le projet d’ordre du jour.","pt":"Um sinal de segurança não comprova causalidade; todas as contagens se baseiam na pauta preliminar.","tr":"Güvenlik sinyali nedensellik kanıtı değildir; tüm sayılar taslak gündem temellidir."},"sourceUrls":["https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october"],"title":{"ar":"إحصاءات لجنة PRAC في أكتوبر","de":"PRAC-Statistik für Oktober","en":"PRAC October statistics","es":"Estadísticas de octubre del PRAC","fr":"Statistiques d’octobre du PRAC","pt":"Estatísticas do PRAC em outubro","tr":"PRAC ekim istatistikleri"},"type":"metrics","updatedAt":"2026-10-12T06:19:32+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=tr&format=csv","json":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=tr&format=json"},"id":"verified-indicators"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Halk sağlığı, araştırma ve bağlantılı verinin kavramsal illüstrasyonu.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"tr","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-4e22bbce-1bd4-5a4f-adf7-eedfd2dca91c","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"ema-prac-october-2026-pharmacovigilance-outcomes","image":null,"importance":0.6,"language":"tr","modified_at":"2026-10-12T06:19:32+03:00","publication_basis":"publication-record","published_at":"2026-10-04T01:05:40+00:00","reading_minutes":1,"region":"world","relations":[],"section_illustration":{"alt":"Halk sağlığı, araştırma ve bağlantılı verinin kavramsal illüstrasyonu.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"tr","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"ema-prac-october-2026-pharmacovigilance-outcomes","sources":[{"checkedAt":"2026-10-04","name":"European Medicines Agency","publishedAt":"2026-10-02","url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october"},{"checkedAt":"2026-10-04","name":"European Medicines Agency PRAC committee calendar","url":"https://www.ema.europa.eu/no/committees/pharmacovigilance-risk-assessment-committee-prac"}],"summary":"PRAC aylık istatistiklerinde 9 güvenlik sinyali, 49 risk yönetim planı ve 16 ruhsat sonrası çalışma bildirdi.","text":"PRAC aylık istatistiklerinde 9 güvenlik sinyali, 49 risk yönetim planı ve 16 ruhsat sonrası çalışma bildirdi.\n\nEMA’nın PRAC güvenlik komitesi 28 Eylül–1 Ekim toplantısının ardından ekim istatistiklerini yayımladı. Ajansın aylık özetinde 85 periyodik güvenlilik güncelleme raporu için tekil değerlendirme, merkezi ruhsatlı ilaçlar için 49 risk yönetim planı ve 16 ruhsat sonrası güvenlilik çalışması bulunuyor.\n\nKomite 9 güvenlik sinyali bildirdi: 5’i başlatılmış, 4’ü süren veya sonuçlanan süreçler olarak listelendi. EMA, toplantıda herhangi bir sevk prosedürünün başlatılmadığını ya da sonuçlandırılmadığını belirtti. Bu sayılar bir zarar bulgusunun veya yeni bir kısıtlamanın kanıtı değildir.\n\nAjans, aylık istatistiklerin taslak gündeme dayandığını söylüyor. Güvenlik sinyali daha fazla inceleme gerektirebilecek olası bir ilaç-olay ilişkisine işaret eder; tek başına nedensellik kanıtı değildir.\n\nBu habere Almanca ve Portekizce çeviriler ile veri ve düzeltme açıklamalarının bu dillerdeki karşılıkları eklendi.\n\nVeri etiketlerindeki veya açıklamalarındaki çeviri ifadeleri düzeltildi.","title":"EMA güvenlik komitesi ekimde 85 ilaç raporunu değerlendirdi","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=en","language":"en","url":"https://newsverum.com/en/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=es","language":"es","url":"https://newsverum.com/es/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=de","language":"de","url":"https://newsverum.com/de/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/ema-prac-october-2026-pharmacovigilance-outcomes"}],"url":"https://newsverum.com/tr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},"version":"1"}
